PERCEPTIVE ADVISORS LLC - 02 Dec 2022 Form 4 Insider Report for Solid Biosciences Inc. (SLDB)

Role: Director, 10%+ Owner
Signature: /s/ Joseph Edelman - for Perceptive Advisors LLC, By: Joseph Edelman, its managing member
Issuer symbol: SLDB
Transactions as of: 02 Dec 2022
Net transactions value: +$15,249,996
Form type: 4
Filing time: 06 Dec 2022, 15:41:27 UTC
Previous filing: 18 Nov 2022
Next filing: 15 Dec 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SLDB	Common Stock	Award	$15,249,996	+2,163,120	+242%	$7.05	3,057,290	02 Dec 2022	See Footnote	F1, F2, F3
transaction	SLDB	Common Stock	Award		+365,536	+12%		3,422,826	02 Dec 2022	See Footnote	F2, F3, F4
transaction	SLDB	Common Stock	Award		+73,107			73,107	02 Dec 2022	See Footnote	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Acquired from the Issuer pursuant to the Securities Purchase Agreement dated September 29, 2022.
F2	Reflects the Issuer's reverse stock split that occurred on October 27, 2022.
F3	The securities are directly held by Perceptive Life Sciences Master Fund Ltd. (the "Master Fund"). Perceptive Advisors LLC (the "Advisor") serves as the investment manager to the Master Fund. Mr. Joseph Edelman is the managing member of the Advisor. Each of Mr. Edelman and the Advisor disclaims, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his/its indirect pecuniary interest therein, and this report shall not be deemed an admission that either Mr. Edelman or the Advisor is the beneficial owner of such securities for purposes of Section 16 or for any other purposes.
F4	Acquired pursuant to the acquisition by the Issuer of AavantiBio, Inc. ("AavantiBio") in exchange for shares of preferred stock of AavantiBio pursuant to the Agreement and Plan of Merger dated September 29, 2022.
F5	The securities are directly held by Perceptive Xontogeny Venture Fund, LP ("Perceptive Xontogeny"). Perceptive Venture Advisors, LLC (the "Venture Advisor") serves as the investment advisor to Perceptive Xontogeny and is an affiliate of the Advisor. Mr. Joseph Edelman is the managing member of the Advisor. The Venture Advisor, the Advisor and Mr. Edelman disclaim, for purposes of Section 16 of the Securities Exchange Act of 1934, beneficial ownership of such securities, except to the extent of his or its indirect pecuniary interest therein, and this report shall not be deemed an admission that they are the beneficial owner of such securities for purposes of Section 16 or for any other purposes.